Erratum: A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.

MLA

Schcolnik-Cabrera, Alejandro, et al. “Erratum: A Combination of Inhibitors of Glycolysis, Glutaminolysis and de Novo Fatty Acid Synthesis Decrease the Expression of Chemokines in Human Colon Cancer Cells.” Oncology Letters, vol. 19, no. 3, Mar. 2020, p. 2071. EBSCOhost, https://doi.org/10.3892/ol.2020.11303.

APA

Schcolnik-Cabrera, A., Dominguez-Gómez, G., Chávez-Blanco, A., Ramírez-Yautentzi, M., Morales-Bárcenas, R., Díaz-Chávez, J., Taja-Chayeb, L., & Dueñas-González, A. (2020). Erratum: A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells. Oncology Letters, 19(3), 2071. https://doi.org/10.3892/ol.2020.11303

Chicago

Schcolnik-Cabrera, Alejandro, Guadalupe Dominguez-Gómez, Alma Chávez-Blanco, Marisol Ramírez-Yautentzi, Rocío Morales-Bárcenas, José Díaz-Chávez, Lucía Taja-Chayeb, and Alfonso Dueñas-González. 2020. “Erratum: A Combination of Inhibitors of Glycolysis, Glutaminolysis and de Novo Fatty Acid Synthesis Decrease the Expression of Chemokines in Human Colon Cancer Cells.” Oncology Letters 19 (3): 2071. doi:10.3892/ol.2020.11303.